Secretagogues govern GH secretory-burst waveform and mass in healthy eugonadal and short-term hypogonadal men

European Journal of Endocrinology

Volumn 159, Issue 5, 2008, Pages 547-554

  Veldhuis, Johannes D ^a   Keenan, Daniel M ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PRALMORELIN; SERMORELIN; SODIUM CHLORIDE; SOMATOSTATIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPOGONADISM; HYPOTHALAMUS; IN VIVO STUDY; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMATOSTATIN RELEASE; WAVEFORM;

ADULT; ESTRADIOL; GROWTH HORMONE-RELEASING HORMONE; HORMONES; HUMAN GROWTH HORMONE; HUMANS; HYPOGONADISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFUSIONS, INTRAVENOUS; MALE; MODELS, BIOLOGICAL; OLIGOPEPTIDES; PULSATILE FLOW; SOMATOSTATIN; TESTIS; TESTOSTERONE;

EID: 56749096817     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0414     Document Type: Article

References (33)

1. Giustina A & Veldhuis ID. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocrine Reviews 1998 19 717-797.
2. Veldhuis JD, Roemmich JN, Richmond EJ & Bowers CY. Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition. Endocrine Reviews 2006 27 101-140.
3. An S & Zenisek D. Regulation of exocytosis in neurons and neuroendocrine cells. Current Opinion in Neurobiology 2004 14 522-530.
4. Alvarez DT, Fernandez-Chacon R & Fernandez JM. Release of secretory products during transient vesicle fusion. Nature 1993 363 554-558.
5. Haluska CK, Riske KA, Marchi-Artzner V, Lehn JM, Lipowsky R & Dimova R. Time scales of membrane fusion revealed by direct imaging of vesicle fusion with high temporal resolution. PNAS 2006 103 15841-15846.
6. Stachura ME, Tyler JM & Kent PG. Pituitary immediate release pools of growth hormone and prolactin are preferentially refilled by new rather than stored hormone. Endocrinology 1989 125 444-449.
7. Keenan DM, Roelfsema F, Biermasz N & Veldhuis JD. Physiological control of pituitary hormone secretory-burst mass, frequency and waveform: a statistical formulation and analysis. American Journal of Physiology 2003 285 R664-R673.
8. Keenan DM, Alexander SL, Irvine CHG, Clarke IJ, Canny BJ, Scott CJ, Tilbrook AJ, Turner AI & Veldhuis JD. Reconstruction of in vivo time-evolving neuroendocrine dose-response properties unveils admixed deterministic and stochastic elements. PNAS 2004 101 6740-6745.
9. Keenan DM, Licinio J & Veldhuis JD. A feedback-controlled ensemble model of the stress-responsive hypothalamo-pituitary-adrenal axis. PNAS 2001 98 4028-4033.
10. Keenan DM, Chattopadhyay S & Veldhuis JD. Composite model of time-varying appearance and disappearance of neurohormone pulse signals in blood. Journal of Theoretical Biology 2005 236 242-255.
11. Keenan DM, Takahashi PY, Liu PY, Roebuck PD, Nehra AX, Iranmanesh A & Veldhuis JD. An ensemble model of the male gonadal axis: illustrative application in aging men. Endocrinology 2006 147 2817-2828.
12. Keenan DM, Evans WS & Veldhuis JD. Control of LH secretory-burst frequency and interpulse-interval regularity in women. American Journal of Physiology 2003 285 E938-E948.
13. Erickson D, Keenan DM, Mielke K, Bradford K, Bowers CY, Miles JM & Veldhuis JD. Dual secretagogue drive of burst-like growth hormone secretion in postmenopausal compared with premeno-pausal women studied under an experimental estradiol clamp. Journal of Clinical Endocrinology and Metabolism 2004 89 4746-4754.
14. Erickson D, Keenan DM, Farhy LS, Mielke K, Bowers CY & Veldhuis JD. Determinants of dual secretagogue drive of burst-like GH secretion in premenopausal women studied under a selective estradiol clamp. Journal of Clinical Endocrinology and Metabolism 2005 90 1741-1751.
15. Anderson SM, Shah N, Evans WS, Patrie JT Bowers CY & Veldhuis JD. Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2001 86 551-560.
16. Veldhuis JD, Evans WS & Bowers CY. Impact of estradiol supplementation on dual peptidyl drive of growth-hormone secretion in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2002 87 859-866.
17. Veldhuis JD, Evans WS & Bowers CY. Estradiol supplementation enhances submaximal feedforward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu. Journal of Clinical Endocrinology and Metabolism 2003 88 5484-5489.
18. Ghigo E, Arvat E & Valente F, Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults. Neuroendocrinology 1991 54 291-294.
19. Alba-Roth J, Muller OA, Schopohl J & Von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. Journal of Clinical Endocrinology and Metabolism 1988 67 1186-1189.
20. Gentili A, Mulligan T, Godschalk M, Clore J, Patric J, Iranmanesh A & Veldhuis JD. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men. Journal of Clinical Endocrinology and Metabolism 2002 87 825-834.
21. Anderson SM, Wideman L, Patrie JT, Weltman A, Bowers CY & Veldhuis JD. Estradiol supplementation selectively relieves GH's autonegative feedback on GH-releasing peptide-2-stimulated GH secretion. Journal of Clinical Endocrinology and Metabolism 2001 86 5904-5911.
22. Veldhuis JD, Evans WS & Johnson ML. Complicating effects of highly correlated model variables on nonlinear least-squares estimates of unique parameter values and their statistical confidence intervals: estimating basal secretion and neurohormone half-life by deconvolution analysis. Methods in Neuroscience 1995 28 130-138.
23. Schwarz G. Estimating the dimension of a model. Annals of Statistics 1978 6 461-464.
24. Faria ACS, Veldhuis JD, Thorner MO & Vance ML. Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin. Journal of Clinical Endocrinology and Metabolism 1989 68 535-541.
25. Veldhuis JD, Carlson ML & Johnson ML. The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. PNAS 1987 84 7686-7690.
26. Hartman ML, Faria AC, Vance ML, Johnson ML, Thorner MO & Veldhuis JD. Temporal structure of in vivo growth hormone secretory events in man. American Journal of Physiology 1991 260 E101-E110.
27. Shah N, Evans WS & Veldhuis JD. Actions of estrogen on the pulsatile, nyctohemeral, and entropic modes of growth hormone secretion. American Journal of Physiology 1999 276 R1351-R1358.
28. Cho SJ, Jeftinija K, Glavaski A, Jeftinija S, Jena BP & Anderson LL. Structure and dynamics of the fusion pores in live GH-secreting cells revealed using atomic force microscopy. Endocrinology 2002 143 1144-1148.
29. Keenan DM & Veldhuis JD. Disruption of the hypothalamic luteinizing-hormone pulsing mechanism in aging men. American Journal of Physiology 2001 281 R1917-R1924.
30. Veldbuis JD, Keenan DM, Iranmanesh A, Mielke K, Miles JM & Bowers CY. Estradiol potentiates ghrelin-stimulated pulsatile GH secretion in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2006 91 3559-3565.
31. Kimura N, Tomizawa S, Arai KN & Kimura N. Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries. Endocrinology 1998 139 1573-1580.
32. Bray MJ, Vick TM, Shah N, Anderson SM, Rice LW, Iranmanesh A, Evans WS & Veldhuis JD. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion. Journal of Clinical Endocrinology and Metabolism 2001 86 3143-3149.
33. Lin S, Lin EJ, Boey D, Lee NJ, Slack K, During MJ, Sainsbury A & Herzog H. Fasting inhibits the growth and reproductive axes via distinct Y2 and Y4 receptor mediated pathways. Endocrinology 2007 148 2056-2065.